These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3809 related articles for article (PubMed ID: 6965225)

  • 1. Deficient strongly adherent monocytes in the peripheral blood of cancer patients.
    Hersh EM; Gschwind C; Morris DL; Murphy S
    Cancer Immunol Immunother; 1982; 14(2):105-9. PubMed ID: 6965225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency in maturation process of macrophages in human cancer.
    Krishnan EC; Menon CD; Krishnan L; Jewell WR
    J Natl Cancer Inst; 1980 Aug; 65(2):273-6. PubMed ID: 6931248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired mononuclear-cell proliferation in patients with the acquired immune deficiency syndrome results from abnormalities of both T lymphocytes and adherent mononuclear cells.
    Shannon K; Cowan MJ; Ball E; Abrams D; Volberding P; Ammann AJ
    J Clin Immunol; 1985 Jul; 5(4):239-45. PubMed ID: 3876352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte dysfunction in human cancer.
    Unger SW; Bernhard MI; Pace RC; Wanebo HJ
    Cancer; 1983 Feb; 51(4):669-74. PubMed ID: 6821839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of monocyte maturation in adherent and suspension cultures and its application to study monocyte differentiation in Hodgkin's disease.
    de Mulder PH; van Rennes H; Mier PD; Bergers M; de Pauw BE; Haanen C
    Clin Exp Immunol; 1983 Dec; 54(3):681-8. PubMed ID: 6360444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of temporarily adherent human mononuclear blood cells in monocyte monolayers.
    Eggen BM
    Int Arch Allergy Appl Immunol; 1983; 72(2):143-9. PubMed ID: 6192097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
    Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the levels of marker expression by mononuclear phagocytes in zinc-deficient mice.
    Wirth JJ; Fraker PJ; Kierszenbaum F
    J Nutr; 1984 Oct; 114(10):1826-33. PubMed ID: 6481478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients.
    Jerrells TR; Dean JH; Richardson G; Cannon GB; Herberman RB
    Int J Cancer; 1979 Jun; 23(6):768-76. PubMed ID: 468410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunotherapy with Corynebacterium parvum and methanol extraction residue of BCG administered intravenously on host defense function in cancer patients.
    Hersh EM; Murphy SG; Quesada JR; Gutterman JU; Gschwind CR; Morgan J
    J Natl Cancer Inst; 1981 Jun; 66(6):993-1002. PubMed ID: 6941048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cancer and chemotherapy on monocyte function.
    Lower EE; Baughman RP
    J Clin Lab Immunol; 1990 Mar; 31(3):121-5. PubMed ID: 1966996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
    Freundlich B; Trinchieri G; Perussia B; Zurier RB
    J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of anti-A-dependent cytotoxicity of human peripheral blood monocytes.
    Bakács T; Tótpál K; Ringwald G; Perl A; Gergely P
    J Clin Lab Immunol; 1986 Mar; 19(3):143-7. PubMed ID: 3486980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological characterization and clinical significance of low mobility cells appearing in the peripheral blood mononuclear cells of cancer patients.
    Mori T; Shimizu M; Iwaguchi T
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1463-9. PubMed ID: 2972547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functions of human monocytes in normal subjects and in disorders associated with immune deficiency.
    Cruchaud A; Girard JP; Hitoglou S
    Int Arch Allergy Appl Immunol; 1977; 54(6):529-37. PubMed ID: 885635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear cells in human lung parenchyma. Characterization of a potent accessory cell not obtained by bronchoalveolar lavage.
    Nicod LP; Lipscomb MF; Weissler JC; Lyons CR; Albertson J; Toews GB
    Am Rev Respir Dis; 1987 Oct; 136(4):818-23. PubMed ID: 2959182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of the serum immunosuppressive factor by monocytes in patients with Crohn's disease.
    Watanabe M; Hibi T; Iwao Y; Kanai T; Ohara M; Fujisawa T; Ogata H; Watanabe N; Asakura H; Aiso S
    J Clin Lab Immunol; 1989 Aug; 29(4):161-6. PubMed ID: 2637362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serum lipid profiles and the ratio and count of the CD16+ monocyte subset in peripheral blood of apparently healthy adults.
    Huang ZS; Chiang BL
    J Formos Med Assoc; 2002 Jan; 101(1):11-7. PubMed ID: 11911032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous cytotoxicity of human peripheral blood mononuclear cells for the lymphoblastoid cell line CCRF-CEM: augmentation by bacterial lipopolysaccharide.
    Schacter B; Kleinhenz ME; Edmonds K; Ellner JJ
    Clin Exp Immunol; 1981 Dec; 46(3):640-8. PubMed ID: 7039896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 191.